Opsumit and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Opsumit (macitentan) and Abilify (aripiprazole). Common drug interactions include musculoskeletal stiffness among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Opsumit and Abilify. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Opsumit?

Opsumit has active ingredients of macitentan. eHealthMe is studying from 67,926 Opsumit users. Check the latest studies of Opsumit.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

72 people who take Opsumit and Abilify together, and have interactions are studied.

Opsumit and Abilify drug interactions.

What are the common drug interactions of Opsumit and Abilify, by gender? *:

female:

  1. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Pain
  4. Peripheral swelling
  5. Platelet count decreased
  6. Prerenal failure
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Rectal haemorrhage (bleeding from anus)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Sinusitis (inflammation of sinus)

male:

  1. Abdominal discomfort
  2. Anxiety
  3. Migraine (headache)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Nausea (feeling of having an urge to vomit)
  6. Nervousness
  7. Pneumonia
  8. Poor quality sleep
  9. Pulmonary hypertension (increase in blood pressure in the lung artery)
  10. Rash

What are the common drug interactions of Opsumit and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Chest pain
  3. Crying
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Abdominal pain
  6. Blood potassium decreased
  7. Dehydration (dryness resulting from the removal of water)
  8. Diarrhoea
  9. Nausea (feeling of having an urge to vomit)
  10. Vomiting

30-39:

  1. Psychotic disorder
  2. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  3. Nausea (feeling of having an urge to vomit)
  4. Diarrhoea
  5. Haematemesis (vomiting of blood)
  6. Hospitalisation
  7. Pain
  8. Platelet count decreased
  9. Prerenal failure
  10. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

40-49:

  1. Dry mouth
  2. Headache (pain in head)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Pulmonary oedema (fluid accumulation in the lungs)
  5. Weight increased
  6. Disease progression
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Haematochezia (passage of stools containing blood)

50-59:

  1. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  2. Urine output decreased
  3. Vertigo
  4. Viral upper respiratory tract infection
  5. Abdominal discomfort
  6. Myalgia (muscle pain)
  7. Sputum discoloured
  8. Cardiac failure congestive
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Chest pain
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Cough
  5. International normalised ratio increased
  6. Pneumonia
  7. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  8. Acute respiratory failure
  9. Cardiac disorder
  10. Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 62 people, 86.11%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 7 people, 9.72%
  3. Psychotic Disorder: 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Opsumit and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Opsumit and Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Opsumit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Opsumit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on macitentan and aripiprazole (the active ingredients of Opsumit and Abilify, respectively), and Opsumit and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: